CD4 and metastatic neoplasm: Although not significant, one study suggested that there was a tendency toward decreased levels of CD3+CD4+ T helper cell and increased levels of CD3+CD8+ T-cells in the peripheral blood of patients with advanced metastatic tumors responding to anti-PD-1 antibody [20].